WHY DOES CANNABIS EFFECT PEOPLE DIFFERENTLY? COMPARING THOSE WITH TEMPORARY PSYCHOTIC SYMPTOMS VS. THOSE WITH NO PSYCHOTIC SYMPTOMS FOLLOWING THE ORAL ADMINISTRATION OF Δ-9-TETRAHYDROCANNABINOL – A FUNCTIONAL MRI STUDY

Zerrin Atakan, Sagnik Bhattacharyya, Paul Allen, Stefan Borgwardt, Paolo Fusar-Poli, Rocio Martin-Santos, Jose A. Crippa, Marc Seal, Joseph P. Kambeitz, Manoharan Andiappan, Daniel Stahl, Antonio W. Zuardi, Philip McGuire
  • Schizophrenia Research, April 2010, Elsevier
  • DOI: 10.1016/j.schres.2010.02.346
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Sagnik Bhattacharyya